Clinical Trial Update: Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study evaluating nitrocamptothecin in patients with advanced ovarian cancer. The trial status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Nitrocamptothecin (nitrocamptothecin)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED